Stockreport

Neurotrope Announces Review of Strategic Alternatives to Maximize Shareholder Value

NextTrip, Inc.  (NTRP) 
PDF NEW YORK, Oct. 8, 2019 /PRNewswire/ -- Neurotrope, Inc. (Nasdaq: NTRP), a clinical-stage biopharmaceutical company developing novel therapies for neurodegenerative disea [Read more]